Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 90 publications
Molecular Biology and Phase 1 Study of GM-CSF and Intrathecal Trastuzumab in Children with Recurrent Posterior Fossa Ependymoma.
Journal: Neuro-oncology
Published: October 26, 2025
Molecular biology and phase 1 study of GM-CSF and intrathecal trastuzumab in children with recurrent -posterior fossa ependymoma.
Journal: Neuro-oncology
Published: October 26, 2025
4-Aminopyridine induced hyperpolarizing oscillations in pediatric human epileptic tissue are network-driven potassium currents that are abolished by activation of KCNQ2-5 (Kv7.2-Kv7.5) channels.
Journal: Neurobiology of disease
Published: October 01, 2025
Phase 3 randomized trial of postirradiation chemotherapy in patients with newly diagnosed ependymoma: A report from the Children's Oncology Group.
Journal: Neuro-oncology
Published: April 17, 2025
Bedside transfontanelle drain placement reduces the need for operative intervention in infants with subdural fluid collections.
Journal: Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery
Published: November 05, 2024
Multi-pronged analysis of pediatric low-grade glioma and ganglioglioma reveals a unique tumor microenvironment associated with BRAF alterations.
Journal: Brain pathology (Zurich, Switzerland)
Published: August 03, 2024
Maintaining Survival While Improving Quality of Life: An Advanced Practitioner-Led Pilot Feasibility Study to Reduce Radiation Dose in Children With Brain Tumors.
Journal: Journal of the advanced practitioner in oncology
Published: July 26, 2024
Characterizing the Diversity of Layer 2/3 Human Neocortical Neurons in Pediatric Epilepsy.
Journal: eNeuro
Published: May 16, 2024
Multi-pronged analysis of pediatric low-grade glioma reveals a unique tumor microenvironment associated with BRAF alterations.
Journal: bioRxiv : the preprint server for biology
Published: April 22, 2024
Long-term follow-up of patients with intermediate-risk neuroblastoma treated with response- and biology-based therapy: A report from the Children's Oncology Group study ANBL0531.
Journal: Pediatric blood & cancer
Published: January 30, 2024
Outcomes of patients with intermediate-risk neuroblastoma presenting with motor deficits relating to intraspinal tumor extension: A report from the Children's Oncology Group study ANBL0531.
Journal: Pediatric blood & cancer
Published: January 12, 2024
Last Updated: 09/26/2026